Spesolimab (BI 655130): IL36R antibody Spesolimab (BI 655130): IL36R antibody Spesolimab (BI 655130): IL36R antibody
Spesolimab (BI 655130): IL36R antibody | PG Spesolimab (BI 655130): IL36R antibody | PG Spesolimab (BI 655130): IL36R antibody | PG
equine asthma equine asthma Fighting Equine Asthma is a crucial step to improving the well-being of many horses worldwide. The right treatment can make a world of difference.
Spesolimab (BI 655130): IL36R antibody Spesolimab (BI 655130): IL36R antibody Spesolimab (BI 655130): IL36R antibody
Purpose: Finding the long-missed meaning Purpose: Finding the long-missed meaning Cancer survivor Missy Pappion is happy at Boehringer Ingelheim after climbing the corporate ladder
global-top-employer global-top-employer For the first time, Boehringer Ingelheim receives the award as a Global Top Employer as well as individual awards in 27 countries.
Vicadrostat (BI 690517) + empagliflozin Vicadrostat (BI 690517) + empagliflozin Vicadrostat (BI 690517) + empagliflozin
university-of-medical-excellence-harvard university-of-medical-excellence-harvard A program designed by Harvard Medical School Executive Education with the goal of accelerating clinical development and medical affairs
The Goals to Improve Living with GPP The Goals to Improve Living with GPP An article that describes the current goals to improve the lives of those living with generalized pustular psoriasis
Rabisin® / Raboral V-RG® Rabisin® / Raboral V-RG® Rabisin® is used for the active immunisation of dogs and cats to reduce mortality and clinical signs due to rabies infection.
The GPP Forum Report The GPP Forum Report The generalized pustular psoriasis (GPP) Forum Report summarizes and highlights the important moments form the multistakeholder GPP Forum
Research Beyond Borders overview Research Beyond Borders overview Learn more about how our Research Beyond Borders team is uncovering new ideas and new science.
Collaboration Boehringer Ingelheim Veeva technology Collaboration Boehringer Ingelheim Veeva technology Boehringer Ingelheim selects Veeva Development Cloud worldwide to bring innovative therapies to patients faster
Generalized pustular psoriasis: Unmet needs Generalized pustular psoriasis: Unmet needs Dr Clerisme-Beaty and Dr Strober MD, PhD discuss the impact of living with GPP including unseen challenges and future management.
BI X colleague about working with purpose BI X colleague about working with purpose Ding works on an app that gives patients remote access to stroke rehabilitation via their mobile phones and tablets
Striving to revolutionize mental health research Striving to revolutionize mental health research World Mental Health Day: Through a precision psychiatry approach and rich pipeline, we are committed to transforming the mental health landscape.
Announcement for Imagine - our new sustainability story hub Announcement for Imagine - our new sustainability story hub Discover Imagine, our sustainability story hub, showcasing how we drive health equity and advance sustainable healthcare solutions for a better future
EASi-HF™ Phase III trial in patients with HFpEF EASi-HF™ Phase III trial in patients with HFpEF Boehringer Ingelheim's Sandy Sommer on the global urgency for innovative heart failure care and the significance of the clinical trial for patients with HFpEF worldwide.
Award: Boehringer Ingelheim is Global Top Employer 2022 Award: Boehringer Ingelheim is Global Top Employer 2022 Global Top Employer 2022
Social innovation: catalyst for sustainable health solutions Social innovation: catalyst for sustainable health solutions Supporting social innovators drives sustainable health solutions in underserved communities. Learn more about Boehringer Ingelheim Social Engagements.
The Boehringer Ingelheim Veterinary Scholars Program The Boehringer Ingelheim Veterinary Scholars Program The aim of the Boehringer Ingelheim Veterinary Scholars Program is to expose students to biomedical research